Naseem Akhtar

1.1k total citations
22 papers, 828 citations indexed

About

Naseem Akhtar is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Naseem Akhtar has authored 22 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Naseem Akhtar's work include Advancements in Transdermal Drug Delivery (7 papers), Advanced Drug Delivery Systems (6 papers) and Lipid Membrane Structure and Behavior (4 papers). Naseem Akhtar is often cited by papers focused on Advancements in Transdermal Drug Delivery (7 papers), Advanced Drug Delivery Systems (6 papers) and Lipid Membrane Structure and Behavior (4 papers). Naseem Akhtar collaborates with scholars based in Saudi Arabia, India and Egypt. Naseem Akhtar's co-authors include Riaz A. Khan, Mohammad Yusuf, Manu Jaggi, Sushama Talegaonkar, Varsha Singh, Roop K. Khar, Tripta Bansal, Abdul Ahad, Hamdoon A. Mohammed and Mohd. Aqil and has published in prestigious journals such as International Journal of Environmental Research and Public Health, Drug Discovery Today and Progress in Lipid Research.

In The Last Decade

Naseem Akhtar

21 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naseem Akhtar Saudi Arabia 15 394 226 204 131 114 22 828
Anuj Garg India 20 345 0.9× 207 0.9× 133 0.7× 98 0.7× 99 0.9× 54 953
Chander Parkash Dora India 18 499 1.3× 330 1.5× 302 1.5× 149 1.1× 145 1.3× 29 1.2k
Mohammed Muqtader Ahmed Saudi Arabia 22 436 1.1× 247 1.1× 238 1.2× 78 0.6× 136 1.2× 81 1.1k
Subramanian Natesan India 19 421 1.1× 302 1.3× 247 1.2× 61 0.5× 181 1.6× 52 1.1k
Omar Awad Alsaidan Saudi Arabia 21 463 1.2× 382 1.7× 231 1.1× 91 0.7× 113 1.0× 94 1.2k
Houli Li China 11 476 1.2× 250 1.1× 204 1.0× 56 0.4× 109 1.0× 21 998
Jong-Suep Baek South Korea 17 463 1.2× 325 1.4× 276 1.4× 83 0.6× 128 1.1× 40 945
Khaled Shalaby Saudi Arabia 19 463 1.2× 233 1.0× 205 1.0× 52 0.4× 97 0.9× 40 1.0k
Suhair Sunoqrot Jordan 21 339 0.9× 368 1.6× 361 1.8× 80 0.6× 193 1.7× 53 1.3k
Young‐Guk Na South Korea 18 348 0.9× 193 0.9× 175 0.9× 43 0.3× 119 1.0× 47 795

Countries citing papers authored by Naseem Akhtar

Since Specialization
Citations

This map shows the geographic impact of Naseem Akhtar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naseem Akhtar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naseem Akhtar more than expected).

Fields of papers citing papers by Naseem Akhtar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naseem Akhtar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naseem Akhtar. The network helps show where Naseem Akhtar may publish in the future.

Co-authorship network of co-authors of Naseem Akhtar

This figure shows the co-authorship network connecting the top 25 collaborators of Naseem Akhtar. A scholar is included among the top collaborators of Naseem Akhtar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naseem Akhtar. Naseem Akhtar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Akhtar, Naseem, Shamshir Khan, Mohd Rashid, et al.. (2023). Discovery of Novel Isonipecotic Acid-Based Heteroaryl Amino Acid Derivatives as Potential Anticonvulsant Agents: Design, Synthesis, In-Silico ADME Study, and Molecular Docking Studies. Journal of Pharmacy And Bioallied Sciences. 15(4). 205–211.
5.
Hussein, Nehia N., Ghassan M. Sulaiman, Salim Albukhaty, et al.. (2023). Silver-Cored Ziziphus Spina-Christi Extract-Loaded Antimicrobial Nanosuspension: Overcoming Multidrug Resistance. Nanomedicine. 18(25). 1839–1854. 18 indexed citations
7.
Akhtar, Naseem, et al.. (2022). SPIONs Conjugate Supported Anticancer Drug Doxorubicin’s Delivery: Current Status, Challenges, and Prospects. Nanomaterials. 12(20). 3686–3686. 28 indexed citations
9.
Al-Omar, Mohsen S., Salman A. A. Mohammed, Mohd Nazam Ansari, et al.. (2020). Pyrethroid-Induced Organ Toxicity and Anti-Oxidant-Supplemented Amelioration of Toxicity and Organ Damage: The Protective Roles of Ascorbic Acid and α-Tocopherol. International Journal of Environmental Research and Public Health. 17(17). 6177–6177. 11 indexed citations
10.
Akhtar, Naseem, Salman A. A. Mohammed, Varsha Singh, et al.. (2020). Liposome-based Drug Delivery of Various Anticancer Agents of Synthetic and Natural Product Origin: a Patent Overview. Pharmaceutical Patent Analyst. 9(3). 87–116. 11 indexed citations
11.
Akhtar, Naseem, Varsha Singh, Mohammad Yusuf, & Riaz A. Khan. (2020). Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomedizinische Technik/Biomedical Engineering. 65(3). 243–272. 126 indexed citations
13.
Ahad, Abdul, et al.. (2015). Transdermal delivery of antidiabetic drugs: formulation and delivery strategies. Drug Discovery Today. 20(10). 1217–1227. 33 indexed citations
14.
Ahad, Abdul, Fahad I. Al‐Jenoobi, Abdullah M. Al‐Mohizea, et al.. (2014). Systemic delivery of β-blockers via transdermal route for hypertension. Saudi Pharmaceutical Journal. 23(6). 587–602. 40 indexed citations
15.
Akhtar, Naseem, Sushama Talegaonkar, Roop Khar, & Manu Jaggi. (2013). Self-Nanoemulsifying Lipid Carrier System for Enhancement of Oral Bioavailability of Etoposide by <I>P</I>-Glycoprotein Modulation: <I>In Vitro</I> Cell Line and <I>In Vivo</I> Pharmacokinetic Investigation. Journal of Biomedical Nanotechnology. 9(7). 1216–1229. 29 indexed citations
16.
Akhtar, Naseem, Sushama Talegaonkar, Roop K. Khar, et al.. (2011). A STABILITY INDICATING HPTLC METHOD FOR THE ANALYSIS OF IRINOTECAN IN BULK DRUG AND MARKETED INJECTABLES. Journal of Liquid Chromatography & Related Technologies. 34(14). 1459–1472. 3 indexed citations
17.
Akhtar, Naseem, Abdul Ahad, Roop K. Khar, et al.. (2011). The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review. Expert Opinion on Therapeutic Patents. 21(4). 561–576. 106 indexed citations
18.
Bansal, Tripta, Naseem Akhtar, Manu Jaggi, Roop K. Khar, & Sushama Talegaonkar. (2009). Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. Drug Discovery Today. 14(21-22). 1067–1074. 133 indexed citations
19.
Ali, Javed, Naseem Akhtar, Yasmin Sultana, Sanjula Baboota, & Alka Ahuja. (2008). Antipsoriatic microemulsion gel formulations for topical drugdelivery of Babchi oil (Psoralea corylifolia). Methods and Findings in Experimental and Clinical Pharmacology. 30(4). 277–277. 42 indexed citations
20.
Akhtar, Naseem, et al.. (2008). Thin-layer chromatographic analysis of psoralen in babchi (Psoralea corylifolia) oil. Acta Chromatographica. 20(2). 277–282. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026